ND

Narayan Dadasaheb Bhosale

Active Director Director DIN 08311783
DIN 08311783 First appointment Dec 2018 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Narayan Dadasaheb Bhosale

Data last updated:

Narayan Dadasaheb Bhosale is a Director at Arsan Biopharma Private Limited (since 2018). The company operates in Chemicals.

DIN 08311783
Primary Designation Director
Industry Chemicals
First Appointment 21 Dec 2018
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arsan Biopharma Private Limited U24110PN2018PTC180973
Director21 Dec 20182018Active

Board colleagues of Narayan Dadasaheb Bhosale

NameDINCompanyDesignation
Sunanda Narayan Bhosale08311784Arsan Biopharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Arsan Biopharma Private Limited
Premium access

Shareholding and investment profile for Narayan Dadasaheb Bhosale

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Narayan Dadasaheb Bhosale

Narayan Dadasaheb Bhosale currently holds 1 directorship: Arsan Biopharma Private Limited (Director, since 21 Dec 2018).

Narayan Dadasaheb Bhosale was first appointed on 21 Dec 2018 as Director at Arsan Biopharma Private Limited.

The current boards of Narayan Dadasaheb Bhosale's companies include Sunanda Narayan Bhosale (Arsan Biopharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available